. [Aducanumab approval for Alzheimer's disease in the USA: the surrender of science]. Rev Neurol. 2021 Oct 16;73(8):296-297. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.